Lemaitre Vascular (LMAT) Non-Current Deffered Revenue (2015 - 2018)
Lemaitre Vascular's (LMAT) quarterly Non-Current Deffered Revenue came in at $530000.0 in Q4 2018, down 5.53% year-on-year from $561000.0 in Q4 2017, and down 1.67% on a QoQ basis from $539000.0 in Q3 2018.
Lemaitre Vascular (LMAT) Non-Current Deffered Revenue (2015 - 2018) Analysis & Trends
Lemaitre Vascular (LMAT) has 4 years of Non-Current Deffered Revenue data on file, last reported at $530000.0 in Q4 2018.
- On a quarterly basis, Non-Current Deffered Revenue fell 5.53% year-over-year to $530000.0 in Q4 2018; TTM through Dec 2018 was $530000.0, a 5.53% decrease from a year earlier, with the FY2018 full-year figure at $530000.0, down 5.53% from the prior year.
- Non-Current Deffered Revenue for Q4 2018 stood at $530000.0, down from $539000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for LMAT reached as high as $561000.0 in Q4 2017 and fell as low as $281000.0 in Q4 2015.
- Historically, Non-Current Deffered Revenue has averaged $481400.0 across 4 years, with a median of $532000.0 in 2017.
- Across the five-year window, Non-Current Deffered Revenue jumped 42.39% in 2017 and declined 5.53% in 2018, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $281000.0 in 2015, then soared by 40.21% to $394000.0 in 2016, then jumped by 42.39% to $561000.0 in 2017, then declined by 5.53% to $530000.0 in 2018.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $530000.0 in Q4 2018, $539000.0 in Q3 2018, and $547000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 163.15 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 530,000.00 |
| Sep 30, 2018 | 539,000.00 |
| Jun 30, 2018 | 547,000.00 |
| Mar 31, 2018 | 554,000.00 |
| Dec 31, 2017 | 561,000.00 |
| Sep 30, 2017 | 534,000.00 |
| Jun 30, 2017 | 452,000.00 |
| Mar 31, 2017 | 422,000.00 |
| Dec 31, 2016 | 394,000.00 |
| Dec 31, 2015 | 281,000.00 |